Paloma Health is a pioneering organization founded by Mark and Darshak, aimed at addressing the long wait times for NHS children's autism and ADHD assessments, which can range from 2 to 10 years. With a mission to provide timely assessments and care within 4 weeks of GP referral, Paloma is transforming the landscape of neurodevelopmental services by redesigning care pathways, developing innovative software and AI tools, and training a specialized clinical workforce. The company has rapidly expanded, raising £5 million in pre-seed funding and growing its team to 80, with plans to hire an additional 100 professionals in the coming year. Paloma Health stands out for its clinically-led approach, commitment to transparency, and a strong culture that prioritizes staff well-being and career development, all while being backed by leading healthcare investors.